vs
Side-by-side financial comparison of CITIUS ONCOLOGY, INC. (CTOR) and American Strategic Investment Co. (NYC). Click either name above to swap in a different company.
American Strategic Investment Co. is the larger business by last-quarter revenue ($6.5M vs $3.9M, roughly 1.6× CITIUS ONCOLOGY, INC.). American Strategic Investment Co. runs the higher net margin — -103.4% vs -140.3%, a 36.9% gap on every dollar of revenue.
Citius Oncology, Inc. is a late-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its core pipeline covers treatments addressing unmet medical needs in hematologic malignancies and solid tumors, primarily serving North American and global oncology care markets.
Strategic Hotels & Resorts is an American REIT in the hospitality industry. It was publicly traded on the New York Stock Exchange as BEE. The company owns 18 luxury hotels, 17 of which are located in the United States and one of which is in Germany.
CTOR vs NYC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $6.5M |
| Net Profit | $-5.5M | $-6.7M |
| Gross Margin | 80.0% | — |
| Operating Margin | -133.2% | -4.8% |
| Net Margin | -140.3% | -103.4% |
| Revenue YoY | — | -56.5% |
| Net Profit YoY | 16.9% | -0.7% |
| EPS (diluted) | $-0.06 | $-2.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $6.5M | ||
| Q3 25 | — | $12.3M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | — | $12.3M | ||
| Q4 22 | — | $-47.0M |
| Q4 25 | $-5.5M | $-6.7M | ||
| Q3 25 | — | $35.8M | ||
| Q2 25 | — | $-41.7M | ||
| Q1 25 | — | $-8.6M | ||
| Q4 22 | — | $-10.1M |
| Q4 25 | 80.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 22 | — | — |
| Q4 25 | -133.2% | -4.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -276.7% | ||
| Q1 25 | — | -36.7% | ||
| Q4 22 | — | — |
| Q4 25 | -140.3% | -103.4% | ||
| Q3 25 | — | 291.4% | ||
| Q2 25 | — | -340.9% | ||
| Q1 25 | — | -69.8% | ||
| Q4 22 | — | 21.5% |
| Q4 25 | $-0.06 | $-2.14 | ||
| Q3 25 | — | $13.60 | ||
| Q2 25 | — | $-16.39 | ||
| Q1 25 | — | $-3.39 | ||
| Q4 22 | — | $-5.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.3M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.4M | $64.8M |
| Total Assets | $110.0M | $445.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.3M | $1.3M | ||
| Q3 25 | — | $3.4M | ||
| Q2 25 | — | $5.3M | ||
| Q1 25 | — | $7.1M | ||
| Q4 22 | — | $9.2M |
| Q4 25 | $58.4M | $64.8M | ||
| Q3 25 | — | $71.4M | ||
| Q2 25 | — | $35.5M | ||
| Q1 25 | — | $77.1M | ||
| Q4 22 | — | $301.1M |
| Q4 25 | $110.0M | $445.2M | ||
| Q3 25 | — | $448.1M | ||
| Q2 25 | — | $464.0M | ||
| Q1 25 | — | $499.4M | ||
| Q4 22 | — | $790.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.4M | $-7.8M |
| Free Cash FlowOCF − Capex | — | $-8.5M |
| FCF MarginFCF / Revenue | — | -131.4% |
| Capex IntensityCapex / Revenue | — | 11.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-14.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.4M | $-7.8M | ||
| Q3 25 | — | $777.0K | ||
| Q2 25 | — | $-2.5M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 22 | — | $-3.8M |
| Q4 25 | — | $-8.5M | ||
| Q3 25 | — | $612.0K | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 22 | — | $-4.5M |
| Q4 25 | — | -131.4% | ||
| Q3 25 | — | 5.0% | ||
| Q2 25 | — | -24.4% | ||
| Q1 25 | — | -25.3% | ||
| Q4 22 | — | 9.6% |
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 0.6% | ||
| Q4 22 | — | -1.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
